Intriguingly, ER stress relievers such as tauroursodeoxycholic acid (TUDCA) [109] and 4-phenylbutyric acid (PBA) [115] increased muscle insulin sensitivity in patients with obesity, supporting the hypothesis of ER stress-mediated lipotoxicity in the skeletal muscle. This evidence concerns the gene INS and obesity disorder.